Vimarsana
Biggest News Aggregation in the World

Castle Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Castle Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Castle Bioscience Today - Breaking & Trending Today

Erik Jones and the Erik Jones Foundation Kick-off Skin Cancer & Melanoma Awareness Month at Kansas Speedway - Vimarsana News

Erik Jones and the Erik Jones Foundation Kick-off Skin Cancer & Melanoma Awareness Month at Kansas Speedway

Erik Jones and the Erik Jones Foundation (EJF) will kick off Skin Cancer and Melanoma Awareness Month this weekend at Kansas Speedway and continue to educate fans throughout the month of May

Castle Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference - Vimarsana News

Castle Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that the Company’s executive management is scheduled to present a company...

Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum - Vimarsana News

Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Mar 12, 2024--

Castle Biosciences Inc (CSTL) Reports Robust Revenue Growth and Improved Margins in 2023 - Vimarsana News

Castle Biosciences Inc (CSTL) Reports Robust Revenue Growth and Improved Margins in 2023

Full-Year Revenue Surges by 60% with Significant Advances in Dermatological and Gastroenterological Diagnostics

Source: yahoo.com
Castle Announces Early Exploratory Study Data for Potential Development of a Complementary Test to Accompany DecisionDx®-UM That Could Aid in the Early Detection of Uveal Melanomas - Vimarsana News

Castle Announces Early Exploratory Study Data for Potential Development of a Complementary Test to Accompany DecisionDx®-UM That Could Aid in the Early Detection of Uveal Melanomas

Renowned eye cancer expert and study investigator, Amy Schefler, M.D., will share early data from a study to explore the potential for developing a complementary test that would be tailored for...